End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
52.3 TWD | -0.19% | -2.61% | -14.40% |
06-12 | CHC Healthcare Group Approves Cash Dividend, Payable on August 1, 2024 | CI |
05-03 | CHC Healthcare Group Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Summary
- Overall, the company has poor fundamentals for a medium to long-term investment strategy.
Weaknesses
- The firm trades with high earnings multiples: 27.97 times its 2024 earnings per share.
- For the last twelve months, sales expectations have been significantly downgraded, which means that less important sales volumes are expected for the current fiscal year over the previous period.
- The sales outlook for the group was lowered in the last twelve months. This change in forecast points out a decline in activity as well as pessimistic analyses of the company.
- For the past year, analysts have significantly revised downwards their profit estimates.
- For the last twelve months, the analysts covering the company have given a bearish overview of EPS estimates, resulting in frequent downward revisions.
- Over the past four months, analysts' average price target has been revised downwards significantly.
- Over the past twelve months, analysts' consensus has been significantly revised downwards.
Ratings chart - Surperformance
Sector: Advanced Medical Equipment & Technology
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-14.40% | 269M | - | ||
+48.19% | 78.59M | - | - | |
+26.13% | 77.74M | - | - |
Financials
Valuation
Momentum
Consensus
Business Predictability
Technical analysis
- Stock Market
- Equities
- 4164 Stock
- Ratings CHC Healthcare Group